2017 annual financial data
Rocket Pharmaceuticals 2017 Net income growth
Direct answer
Net income growth was 31.17%.
Operating income was -26,737,000 USD and net income was -29,497,000 USD.
Operating cash flow was -26,112,000 USD.
Get free Rocket Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,737,000 USD
- Net income
- -29,497,000 USD
- Operating cash flow
- -26,112,000 USD